SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026731
Filing Date
2021-05-12
Accepted
2021-05-12 07:00:46
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20210331.htm   iXBRL 10-Q 977719
2 EX-10.1 nerv-ex101_185.htm EX-10.1 17025
3 EX-10.2 nerv-ex102_184.htm EX-10.2 17534
4 EX-10.3 nerv-ex103_183.htm EX-10.3 15976
5 EX-31.1 nerv-ex311_7.htm EX-31.1 20371
6 EX-31.2 nerv-ex312_6.htm EX-31.2 20218
7 EX-32.1 nerv-ex321_8.htm EX-32.1 9902
  Complete submission text file 0001564590-21-026731.txt   4435365

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA nerv-20210331.xsd EX-101.SCH 40756
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20210331_cal.xml EX-101.CAL 32823
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20210331_def.xml EX-101.DEF 132074
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20210331_lab.xml EX-101.LAB 315433
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20210331_pre.xml EX-101.PRE 249345
13 EXTRACTED XBRL INSTANCE DOCUMENT nerv-10q_20210331_htm.xml XML 638097
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 21913418
SIC: 2834 Pharmaceutical Preparations